Pathophysiology of myocardial infarction
Pro Research Analysisby 
Searched over 200M research papers
Consensus Meter
Pathophysiology of Myocardial Infarction
Introduction to Myocardial Infarction Pathophysiology
Myocardial infarction (MI), commonly known as a heart attack, is characterized by the sudden ischemic death of myocardial tissue. This condition is primarily caused by the thrombotic occlusion of a coronary vessel, often due to the rupture of a vulnerable plaque. The pathophysiology of MI involves a complex interplay of metabolic, ionic, and cellular changes that lead to myocardial injury and subsequent healing processes.
Ischemia and Initial Cellular Responses
Metabolic and Ionic Perturbations
Ischemia, the reduction of blood flow to the heart muscle, induces significant metabolic and ionic disturbances in the affected myocardium. These changes result in a rapid decline in systolic function, which is the heart's ability to contract and pump blood. Prolonged ischemia triggers a "wavefront" of cardiomyocyte death, starting from the subendocardium (inner layer) and extending to the subepicardium (outer layer).
Mitochondrial Alterations and Cell Death
Mitochondrial dysfunction plays a crucial role in the apoptosis (programmed cell death) and necrosis (uncontrolled cell death) of cardiomyocytes during an infarction. The adult mammalian heart has limited regenerative capacity, leading to the formation of scar tissue as the primary healing mechanism.
Inflammatory Response and Infarct Healing
Inflammatory Cascade
The healing process of the infarcted myocardium is heavily dependent on an inflammatory cascade. This cascade is initiated by alarmins, which are molecules released by dying cells that signal danger to the immune system. The infiltration of phagocytes, which clear dead cells and matrix debris, subsequently activates anti-inflammatory pathways. This leads to the suppression of cytokine and chemokine signaling, which are involved in inflammation.
Fibroblast Activation and Scar Formation
The renin-angiotensin-aldosterone system and transforming growth factor-β (TGF-β) play significant roles in converting fibroblasts into myofibroblasts. These myofibroblasts are responsible for depositing extracellular matrix proteins, which contribute to scar formation.
Geometric Remodeling and Long-term Effects
Chamber Dilation and Hypertrophy
Infarct healing is closely linked with geometric remodeling of the heart chamber. This remodeling is characterized by dilation (enlargement) of the heart chamber and hypertrophy (thickening) of the viable myocardial segments. Over time, this can lead to progressive dysfunction of the heart.
Complications and Treatment Strategies
The pathophysiologic changes associated with MI can lead to various complications, including heart failure and arrhythmias. Established treatment strategies, such as reperfusion therapy, aim to restore blood flow and minimize myocardial damage. However, the effectiveness of these treatments can vary, and ongoing research is focused on developing new therapeutic approaches .
Special Cases: MINOCA and Perioperative MI
Myocardial Infarction with Nonobstructive Coronary Arteries (MINOCA)
MINOCA is a unique clinical entity where patients present with MI symptoms but have nonobstructive coronary arteries. The prevalence of MINOCA is about 6%, and it is more common in younger patients and women. Potential pathophysiological mechanisms include coronary artery spasm, myocarditis, and thrombophilia disorders.
Perioperative Myocardial Infarction
Perioperative MI occurs in the context of noncardiac surgery and is often driven by increased cardiac metabolic demand rather than plaque rupture. Demand ischemia is the predominant cause, highlighting the need for careful preoperative evaluation and management.
Conclusion
The pathophysiology of myocardial infarction involves a complex interplay of ischemic injury, inflammatory responses, and healing processes. Understanding these mechanisms is crucial for developing effective treatment strategies and improving patient outcomes. Ongoing research continues to uncover new insights and therapeutic approaches to address the challenges associated with MI.
Sources and full results
Most relevant research papers on this topic